Fudan University: Lymphoma, Large B-Cell, Diffuse trials

The registry lists 13 Lymphoma, Large B-Cell, Diffuse studies with Fudan University as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 9Phase 3 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PETRecruitingNCT07070648
• Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous TransplantationRecruitingNCT07001540Phase 2
• An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell LymphomaRecruitingNCT06517004Phase 1
• ZR-CHOP in DLBCL With Specific Gene AbnormalityRecruitingNCT05290337Phase 2
• R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS RelapseRecruitingNCT05257018Phase 2
• A Study to Evaluate Efficacy and Safety of Zanubrutinib With R-CHOP in Newly Diagnosed Non-GCB DLBCL Patients With Double ExpressionActive, not recruitingNCT05189197Phase 2
• Gene Abnormalities and Prognosis in Diffuse Large B-cell LymphomaStatus unknownNCT04825899
• Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma PatientsCompletedNCT04164368Phase 2
• Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)Status unknownNCT03373019Phase 2
• Thalidomide Combined With R-CHOP in Newly Diagnosed，Untreated Double-expressor Diffuse Large B-Cell Lymphoma PatientsStatus unknownNCT03318835Phase 3
• Dose-adjusted EPOCH-R in MYC Positive DLBCLTerminatedNCT01914718Phase 2
• Interim PET/CT Guided Cycle Numbers of R-CHOP in DLBCLStatus unknownNCT01804127Phase 2
• R-ESHAP Followed by Autologous Transplantation for Refractory or Relapsed Diffused Large B-cell LymphomaStatus unknownNCT01278602Phase 2